News|Videos|October 26, 2023
ASCENT Study: Impact of Sacituzumab Govitecan on Metastatic TNBC
Author(s)Nour Abuhadra, MD
Shay Elkins, a patient with metastatic triple-negative breast cancer, discussed her experience with second-line treatment. Dr. Noor provided insights into the positive outcomes from the ASCENT study.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
3
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
4
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
5